Find the answers you need to accelerate R&D
productivity with a selective and easily accessible
collection of scientific databases.


Accelrys Available Chemicals Directory (ACD)

Accelrys ACD is the Gold Standard for chemical sourcing in pharmaceutical, biotechnology, chemical, and agrochemical companies worldwide—used and trusted for more than 25 years by over 20,000 scientists at over 500 sites.

New for 2013: Accelrys ACD now includes more than 580,000 in-stock building blocks from more than 200 trusted eMolecules suppliers. By adding eMolecules compounds and identifiers into Accelrys ACD, and with the Accelrys ACD identifiers included in the eMolecules catalog, scientists can now:

  • Identify the optimal set of compounds for their synthesis or library, with confidence that those compounds will be available at the indicated prices from the selected suppliers
  • Quickly, easily and confidently order their compounds from multiple suppliers using the eMolecules fulfillment service

ACD consolidates chemical supplier catalogs into an easy-to-access, structure-searchable database providing information on:

  • Product purities
  • Available quantities
  • Prices with supplier ordering information
  • Forms
  • Grades

Accelrys ACD is one of the largest structure-searchable collections of commercially available chemicals in the world, with pricing and supplier information for:

  • Over 7 million unique chemicals, including 3D models
  • Over 15 million products
  • Over 41 million packages
  • From about 940 suppliers

With Accelrys ACD you can:

  • Identify and locate commercial sources
  • Make side-by-side comparisons of purity, quantity and price
  • Save valuable time by accessing information from a single source

Using powerful chemical search functionality it is easy to find suppliers providing analogs of interest. The database also includes 3D models and links to ChemADVISOR EH&S health and safety data.

Accelrys offers multiple options for deploying ACD content.

Browse By:

How does your company measure up? take the free maturity model assessment and start realizing faster,repeatable results from r and d investments.